Edge Wealth Management LLC Amgen Inc Transaction History

Edge Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 14, 2022	SELL	$219.27 - $242.57 $5,920 - $6,549	-27 Closed	0 $0
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $10,540 - $12,062	-53 Reduced 66.25%	27 $6,000
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $10,540 - $12,062	53 Added 196.3%	80 $6,000
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $5,731 - $6,714	27 New	27 $6,000
Q3 2020 Oct 21, 2020	SELL	$234.65 - $260.95 $46,930 - $52,190	-200 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$167.29 - $191.0 $33,458 - $38,200	200	200 $37,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Edge Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edge Wealth Management LLC with notifications on news.